Halladay Benjamin bought ESPR
March 13, 2026 · Form 4 insider transaction
Halladay Benjamin bought 247,430 shares of Esperion Therapeutics, Inc. Common Stock at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
247,430
Price
$0.00
Total value
N/A
InsiderHalladay Benjamin
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 13, 2026
Filing dateMarch 16, 2026
Shares owned after720,026
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be June 15, 2026.; Includes 5,071 shares recently acquired in Esperion's Employee Stock Purchase Plan.